Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.

Rudner L, Nydegger S, Coren LV, Nagashima K, Thali M, Ott DE.

J Virol. 2005 Apr;79(7):4055-65.

2.

Site-specific labeling of the type 1 ryanodine receptor using biarsenical fluorophores targeted to engineered tetracysteine motifs.

Fessenden JD, Mahalingam M.

PLoS One. 2013 May 28;8(5):e64686. doi: 10.1371/journal.pone.0064686. Print 2013.

3.
5.
6.

Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.

Dorweiler IJ, Ruone SJ, Wang H, Burry RW, Mansky LM.

J Virol. 2006 Apr;80(7):3634-43.

7.

Visualizing hepatitis B virus with biarsenical labelling in living cells.

Sun S, Yan J, Xia C, Lin Y, Jiang X, Liu H, Ren H, Yan J, Lin J, He X.

Liver Int. 2014 Nov;34(10):1532-42. doi: 10.1111/liv.12419. Epub 2013 Dec 23.

PMID:
24373334
8.
9.

The biarsenical dye Lumio exhibits a reduced ability to specifically detect tetracysteine-containing proteins within live cells.

Hearps AC, Pryor MJ, Kuusisto HV, Rawlinson SM, Piller SC, Jans DA.

J Fluoresc. 2007 Nov;17(6):593-7. Epub 2007 Sep 6.

PMID:
17805945
10.

Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.

Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG.

J Virol. 2004 Oct;78(19):10803-13.

11.
12.

ReAsH: another viable option for in vivo protein labelling in Dictyostelium.

Hwang RD, Chen CC, Knecht DA.

J Microsc. 2009 Apr;234(1):9-15. doi: 10.1111/j.1365-2818.2009.03149.x.

14.

ReAsH/FlAsH labeling and image analysis of tetracysteine sensor proteins in cells.

Irtegun S, Ramdzan YM, Mulhern TD, Hatters DM.

J Vis Exp. 2011 Aug 31;(54). pii: 2857. doi: 10.3791/2857.

15.

Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.

Milev MP, Brown CM, Mouland AJ.

Retrovirology. 2010 May 10;7:41. doi: 10.1186/1742-4690-7-41.

16.
17.

Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.

Liao WH, Huang KJ, Chang YF, Wang SM, Tseng YT, Chiang CC, Wang JJ, Wang CT.

J Virol. 2007 May;81(10):5155-65. Epub 2007 Mar 7.

18.

Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.

Goff A, Ehrlich LS, Cohen SN, Carter CA.

J Virol. 2003 Sep;77(17):9173-82.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk